MX379899B - Terapia de combinacion de activador de miosina cardiaca e inhibidor de corriente if del nodo sinusal - Google Patents

Terapia de combinacion de activador de miosina cardiaca e inhibidor de corriente if del nodo sinusal

Info

Publication number
MX379899B
MX379899B MX2017016347A MX2017016347A MX379899B MX 379899 B MX379899 B MX 379899B MX 2017016347 A MX2017016347 A MX 2017016347A MX 2017016347 A MX2017016347 A MX 2017016347A MX 379899 B MX379899 B MX 379899B
Authority
MX
Mexico
Prior art keywords
sinus node
cardiac myosin
combination therapy
current inhibitor
myosin activator
Prior art date
Application number
MX2017016347A
Other languages
English (en)
Other versions
MX2017016347A (es
Inventor
Robert Andrew Donald Scott
Scott Wasserman
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of MX2017016347A publication Critical patent/MX2017016347A/es
Publication of MX379899B publication Critical patent/MX379899B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describen en la presente terapias de combinación para el tratamiento de insuficiencia cardíaca mediante el uso del activador de miosina cardíaca, tal como omecamtiv mecarbil, y un inhibidor de corriente If del nodo sinusal. Se describen adicionalmente en la presente composiciones que comprenden un activador de miosina cardíaca y un inhibidor de corriente If del nodo sinusal.
MX2017016347A 2015-06-26 2016-06-24 Terapia de combinacion de activador de miosina cardiaca e inhibidor de corriente if del nodo sinusal MX379899B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562185306P 2015-06-26 2015-06-26
PCT/US2016/039198 WO2016210240A1 (en) 2015-06-26 2016-06-24 Combination therapy of cardiac myosin activator and sinus node if current inhibitor

Publications (2)

Publication Number Publication Date
MX2017016347A MX2017016347A (es) 2018-08-15
MX379899B true MX379899B (es) 2025-03-11

Family

ID=56409184

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016347A MX379899B (es) 2015-06-26 2016-06-24 Terapia de combinacion de activador de miosina cardiaca e inhibidor de corriente if del nodo sinusal

Country Status (7)

Country Link
US (2) US10543215B2 (es)
EP (1) EP3313444B1 (es)
JP (1) JP6858716B2 (es)
AU (1) AU2016282985B2 (es)
CA (1) CA2988796A1 (es)
MX (1) MX379899B (es)
WO (1) WO2016210240A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06014495A (es) 2004-06-17 2007-03-01 Cytokinetics Inc Compuestos, composiciones y metodos.
KR102474467B1 (ko) 2013-03-14 2022-12-05 암젠 인크 복소환식 화합물 및 그들의 용도
TWI769272B (zh) 2017-06-30 2022-07-01 美商安進公司 奧美卡替莫卡必爾的合成
WO2019006235A1 (en) * 2017-06-30 2019-01-03 Amgen Inc. METHODS OF TREATING CARDIAC INSUFFICIENCY WITH CARDIAC SARCOMER ACTIVATORS
EA202090688A1 (ru) 2017-09-13 2020-07-06 Эмджен Инк. Бис-амидные соединения, активирующие саркомер, и варианты их применения
EP3594199B1 (en) 2018-07-09 2020-07-01 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Crystalline 2-fluoro-3-nitrotoluene and process for the preparation thereof
JP2021534138A (ja) 2018-08-17 2021-12-09 アムジエン・インコーポレーテツド オメカムチブメカルビルの塩及び結晶形態
WO2020131574A1 (en) 2018-12-18 2020-06-25 Amgen Inc. Method of reducing aromatic nitro compounds
SI4243825T1 (sl) 2020-11-12 2026-01-30 Amgen Inc. Omekamtiv mekarbil za zdravljenje srčnega popuščanja pri izbranih skupinah bolnikov
US11702380B2 (en) 2021-03-10 2023-07-18 Amgen Inc. Synthesis of omecamtiv mecarbil
US11986474B1 (en) 2023-06-27 2024-05-21 Cytokinetics, Incorporated Methods for treating heart failure by administering cardiac sarcomere activators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
MXPA06014495A (es) * 2004-06-17 2007-03-01 Cytokinetics Inc Compuestos, composiciones y metodos.
FR3001151B1 (fr) * 2013-01-21 2016-04-08 Pf Medicament Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant
KR102474467B1 (ko) * 2013-03-14 2022-12-05 암젠 인크 복소환식 화합물 및 그들의 용도

Also Published As

Publication number Publication date
MX2017016347A (es) 2018-08-15
US10543215B2 (en) 2020-01-28
JP6858716B2 (ja) 2021-04-14
AU2016282985B2 (en) 2021-07-29
AU2016282985A1 (en) 2017-12-14
CA2988796A1 (en) 2016-12-29
EP3313444A1 (en) 2018-05-02
US20200108076A1 (en) 2020-04-09
WO2016210240A1 (en) 2016-12-29
EP3313444B1 (en) 2020-10-21
JP2018518501A (ja) 2018-07-12
US20180140611A1 (en) 2018-05-24

Similar Documents

Publication Publication Date Title
MX379899B (es) Terapia de combinacion de activador de miosina cardiaca e inhibidor de corriente if del nodo sinusal
MX2016016337A (es) Polipeptidos apelina.
MX2022007989A (es) Composiciones y metodos para tratar pterigion.
EP4417262A3 (en) Combination therapy
MX378273B (es) Compuestos activos hacia bromodominios.
MX2017003516A (es) Derivados de pirazol como estimuladores de guanilato ciclasa soluble (sgc).
BR112016029041A2 (pt) terapia de combinação com inibidores de glutaminase
MX2018006632A (es) Inhibidores biciclicos de peptidilarginina deiminasa 4 (pad4).
WO2015142001A3 (ko) 강심 활성을 갖는 화합물 및 이를 함유하는 심부전 예방 또는 치료용 약학적 조성물
PH12021553074A1 (en) 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
EP4364796A3 (en) Use of linagliptin in cardio- and renoprotective antidiabetic therapy
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
MX2018006700A (es) Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
MY199442A (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
PH12018500315A1 (en) Fumagillol heterocyclic compounds and methods of making and using same
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2017001674A (es) Inhibidores de myh7b y usos de los mismos.
ZA202503387B (en) Semaglutide in medical therapy
GB201213484D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods of using the same
MX382092B (es) Compuestos heterocíclicos para el tratamiento de enfermedades.
MX370897B (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades,
EP3259346A4 (en) P63 inactivation for the treatment of heart failure
MX2015012164A (es) Métodos de tratamiento de enfermedad renal y otros trastornos.
HK40019141A (en) Compositions and methods for treating heart failure
NZ772098A (en) 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)